Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
BioMarin Pharmaceutical |
---|---|
Information provided by: | BioMarin Pharmaceutical |
ClinicalTrials.gov Identifier: | NCT00787995 |
This multicenter, multinational, cross-sectional study in subjects diagnosed with MPS IVA will better characterize the spectrum of symptoms and biochemical abnormalities in MPS IVA disease.
Condition |
---|
MPS IV A |
Study Type: | Observational |
Study Design: | Case-Only, Cross-Sectional |
Official Title: | A Multicenter, Multinational, Cross-Sectional Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome) |
Blood and urine collected
Estimated Enrollment: | 300 |
Study Start Date: | October 2008 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
MPS IVA
Subjects with mucopolysaccharidosis IVA (Morquio Syndrome)
|
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Subjects diagnosed with MPS IVA
Inclusion Criteria:
Exclusion Criteria:
Contact: Candice F Henkel | US 1-866-961-8212 | |
Contact: Candice F Henkel | Int'l +1-866-990-6774 [MPS4] |
United States, California | |
Recruiting | |
Oakland, California, United States | |
United States, Illinois | |
Recruiting | |
Chicago, Illinois, United States | |
United Kingdom | |
Recruiting | |
Birmingham, United Kingdom | |
Recruiting | |
London, United Kingdom | |
Recruiting | |
Manchester, United Kingdom |
Study Director: | Celeste Decker, MD | BioMarin Pharmaceutical |
Responsible Party: | BioMarin Pharmaceutical Inc. ( BioMarin Pharmaceutical Inc. ) |
Study ID Numbers: | MOR-001 |
Study First Received: | November 6, 2008 |
Last Updated: | April 7, 2009 |
ClinicalTrials.gov Identifier: | NCT00787995 History of Changes |
Health Authority: | United States: Institutional Review Board; United Kingdom: Research Ethics Committee |
Mucopolysaccharidosis IV type A MPS IV Type A Mucopolysaccharidosis IVA MPS IVA Morquio A Syndrome Lysosomal Storage Disorder |
LSD N-acetylgalactosamine-6-sulfatase galactose-6-sulfatase GALNS enzyme replacement therapy ERT |
Metabolic Diseases Lysosomal Storage Diseases Osteochondrodysplasias Bone Diseases Metabolism, Inborn Errors Mucopolysaccharidoses Morquio Syndrome |
Genetic Diseases, Inborn Musculoskeletal Diseases Mucopolysaccharidosis IV Connective Tissue Diseases Bone Diseases, Developmental Metabolic Disorder Eccentrochondrodysplasia |
Disease Metabolic Diseases Lysosomal Storage Diseases Osteochondrodysplasias Mucinoses Bone Diseases Metabolism, Inborn Errors Mucopolysaccharidoses |
Pathologic Processes Musculoskeletal Diseases Genetic Diseases, Inborn Mucopolysaccharidosis IV Syndrome Connective Tissue Diseases Bone Diseases, Developmental Carbohydrate Metabolism, Inborn Errors |